PL353064A1 - Nowe chalkony - Google Patents

Nowe chalkony

Info

Publication number
PL353064A1
PL353064A1 PL00353064A PL35306400A PL353064A1 PL 353064 A1 PL353064 A1 PL 353064A1 PL 00353064 A PL00353064 A PL 00353064A PL 35306400 A PL35306400 A PL 35306400A PL 353064 A1 PL353064 A1 PL 353064A1
Authority
PL
Poland
Prior art keywords
medicament
prevention
manufacture
useful
treatment
Prior art date
Application number
PL00353064A
Other languages
English (en)
Inventor
Ezio Bombardelli
Piero Valenti
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of PL353064A1 publication Critical patent/PL353064A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL00353064A 1999-09-03 2000-08-28 Nowe chalkony PL353064A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920910.8A GB9920910D0 (en) 1999-09-03 1999-09-03 Novel chalcones
PCT/EP2000/008366 WO2001017988A1 (en) 1999-09-03 2000-08-28 Novel chalcones

Publications (1)

Publication Number Publication Date
PL353064A1 true PL353064A1 (pl) 2003-10-06

Family

ID=10860346

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353064A PL353064A1 (pl) 1999-09-03 2000-08-28 Nowe chalkony

Country Status (21)

Country Link
US (1) US6620842B2 (pl)
EP (1) EP1212315B1 (pl)
JP (1) JP2003508527A (pl)
KR (1) KR100819576B1 (pl)
CN (1) CN1177843C (pl)
AT (1) ATE235483T1 (pl)
AU (1) AU776226B2 (pl)
CA (1) CA2382130A1 (pl)
CZ (1) CZ2002787A3 (pl)
DE (1) DE60001851T2 (pl)
DK (1) DK1212315T3 (pl)
ES (1) ES2193106T3 (pl)
GB (1) GB9920910D0 (pl)
HK (1) HK1043999B (pl)
HU (1) HUP0202579A3 (pl)
NO (1) NO20021049L (pl)
PL (1) PL353064A1 (pl)
PT (1) PT1212315E (pl)
RU (1) RU2252938C2 (pl)
SK (1) SK3112002A3 (pl)
WO (1) WO2001017988A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60333094D1 (de) 2002-04-17 2010-08-05 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren
US7638554B2 (en) * 2002-04-18 2009-12-29 Sri International Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
US20030229136A1 (en) * 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
EP1539727B1 (en) 2002-07-17 2009-02-18 Cytokinetics, Inc. Compounds, compositions, and methods for treating cellular proliferative diseases
US6864264B1 (en) * 2002-08-20 2005-03-08 Gloria L. Anderson 1-adamantyl chalcones for the treatment of proliferative disorders
CN100336797C (zh) * 2005-08-19 2007-09-12 浙江大学 四取代查耳酮衍生物及制备方法和用途
CN104169267B (zh) * 2012-03-01 2017-03-01 香港理工大学 含炔烃的类黄酮、含叠氮化物的类黄酮和含三唑的类黄酮作为调节剂用于癌症的多药耐药

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT58310A (en) * 1988-12-21 1992-02-28 Upjohn Co Anti-atherosclerotic and anti-thrombotic 1-benzopyran-4-one- and 2-amino-1,3-benzoxazin-4-one derivatives, process for producing them and pharmaceutical compositions containing them
US5023341A (en) * 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
AU7963691A (en) * 1990-05-17 1991-12-10 Baylor College Of Medicine Growth inhibitors and methods of treating cancer and cell proliferative diseases
IT1271301B (it) * 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
US5525625A (en) * 1995-01-24 1996-06-11 Warner-Lambert Company 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders

Also Published As

Publication number Publication date
US20030055056A1 (en) 2003-03-20
KR100819576B1 (ko) 2008-04-22
EP1212315B1 (en) 2003-03-26
HUP0202579A3 (en) 2003-07-28
US6620842B2 (en) 2003-09-16
EP1212315A1 (en) 2002-06-12
DE60001851T2 (de) 2003-12-11
CN1371372A (zh) 2002-09-25
GB9920910D0 (en) 1999-11-10
RU2252938C2 (ru) 2005-05-27
ATE235483T1 (de) 2003-04-15
HK1043999A1 (en) 2002-10-04
CN1177843C (zh) 2004-12-01
KR20020031598A (ko) 2002-05-02
DE60001851D1 (de) 2003-04-30
SK3112002A3 (en) 2003-10-07
AU7510900A (en) 2001-04-10
AU776226B2 (en) 2004-09-02
NO20021049L (no) 2002-05-03
HK1043999B (en) 2003-08-15
DK1212315T3 (da) 2003-06-23
CA2382130A1 (en) 2001-03-15
ES2193106T3 (es) 2003-11-01
NO20021049D0 (no) 2002-03-01
JP2003508527A (ja) 2003-03-04
HUP0202579A2 (hu) 2002-11-28
CZ2002787A3 (cs) 2002-06-12
PT1212315E (pt) 2003-08-29
WO2001017988A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
DE60038038D1 (en) Phosphonatverbindungen
IL156437A0 (en) Compositions of estrogen-cyclodextrin complexes
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
NZ508877A (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-L-carnitine and genistein
BG105270A (en) Tetrahydropyridoethers
BG105161A (en) Benzocycloheptenes, methods for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
AP2000001898A0 (en) Vitronectin receptor antagonists
SI0989973T1 (sl) Halkoni z antiproliferativno aktivnostjo
GB9920910D0 (en) Novel chalcones
CA2384433A1 (en) Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
WO2002020000A3 (en) Combined estrogen blockade of the breast with exemestane and raloxifene
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
EP0838461A3 (en) Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity
WO1999061406A3 (en) Antiangiogenic drug to treat cancer, arthritis and retinopathy
WO2003030884A3 (en) Use of solasonine for the treatment of skin tumors
BG106428A (en) Pharmaceutical compositions for treating psoriasis
WO2003037269A3 (en) Di-, tri,- and tetra-peptides having antiangiogenic activity
IL150082A0 (en) Unsaturated 14, 15-cyclopropane-andostranes, a method for their production and pharmaceutical compositions containing these compounds
UA42301A (uk) Засіб "камілаль" для лікування і профілактики проктологічних захворювань
ITBO990597A0 (it) Ortesi ortopedica per il trattamento di epicondiliti .
ES1039452U (es) Placa de osteotomia triple de cadera mejorada.
GR990200198U (en) Corset for protecting pelvis region from fractures
ZA200004651B (en) Xylitol compositions for treating upper respiratory conditions.

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed